321 related articles for article (PubMed ID: 30928169)
21. Individualized management of follicular lymphoma.
Bai B; Huang HQ
Chin Clin Oncol; 2015 Mar; 4(1):7. PubMed ID: 25841714
[TBL] [Abstract][Full Text] [Related]
22. Treatment of Histologic Transformation.
Casulo C
Hematol Oncol Clin North Am; 2020 Aug; 34(4):785-794. PubMed ID: 32586581
[TBL] [Abstract][Full Text] [Related]
23. How to manage early-stage follicular lymphoma.
Cencini E; Fabbri A; Mecacci B; Bocchia M
Expert Rev Hematol; 2020 Oct; 13(10):1093-1105. PubMed ID: 32869685
[TBL] [Abstract][Full Text] [Related]
24. Double-hit follicular lymphoma with MYC and BCL2 translocations: a study of 7 cases with a review of literature.
Miao Y; Hu S; Lu X; Li S; Wang W; Medeiros LJ; Lin P
Hum Pathol; 2016 Dec; 58():72-77. PubMed ID: 27544800
[TBL] [Abstract][Full Text] [Related]
25. Recommendations for Clinical Trial Development in Follicular Lymphoma.
Maddocks K; Barr PM; Cheson BD; Little RF; Baizer L; Kahl BS; Leonard JP; Fowler N; Gordon LI; Link BK; Friedberg JW; Ansell SM
J Natl Cancer Inst; 2017 Mar; 109(3):. PubMed ID: 28040699
[TBL] [Abstract][Full Text] [Related]
26. Stem cell transplantation for follicular lymphoma relapsed/refractory after prior rituximab: a comprehensive analysis from the NCCN lymphoma outcomes project.
Evens AM; Vanderplas A; LaCasce AS; Crosby AL; Nademanee AP; Kaminski MS; Abel GA; Millenson M; Czuczman MS; Rodriguez MA; Niland J; Zelenetz AD; Gordon LI; Friedberg JW
Cancer; 2013 Oct; 119(20):3662-71. PubMed ID: 23921646
[TBL] [Abstract][Full Text] [Related]
27. Follicular lymphoma: 2012 update on diagnosis and management.
Freedman A
Am J Hematol; 2012 Oct; 87(10):988-95. PubMed ID: 23001911
[TBL] [Abstract][Full Text] [Related]
28. New concepts in follicular lymphoma biology: From BCL2 to epigenetic regulators and non-coding RNAs.
Devan J; Janikova A; Mraz M
Semin Oncol; 2018 Oct; 45(5-6):291-302. PubMed ID: 30360879
[TBL] [Abstract][Full Text] [Related]
29. Transformed follicular lymphoma.
Fischer T; Zing NPC; Chiattone CS; Federico M; Luminari S
Ann Hematol; 2018 Jan; 97(1):17-29. PubMed ID: 29043381
[TBL] [Abstract][Full Text] [Related]
30. Soluble Interleukin-2 Receptor Level at Diagnosis Predicts Prognosis of Patients With Follicular Lymphoma Irrespective of Initial Management Strategy.
Yamamoto M; Tanaka K; Umezawa Y; Nagao T; Toyota S; Miura O
Anticancer Res; 2019 Sep; 39(9):5115-5122. PubMed ID: 31519623
[TBL] [Abstract][Full Text] [Related]
31. Prognostic factors in follicular lymphoma: new tools to personalize risk.
Casulo C
Hematology Am Soc Hematol Educ Program; 2016 Dec; 2016(1):269-276. PubMed ID: 27913491
[TBL] [Abstract][Full Text] [Related]
32. A retrospective study on the management of patients with rituximab refractory follicular lymphoma.
Solal-Céligny P; Leconte P; Bardet A; Hernandez J; Troussard X
Br J Haematol; 2018 Jan; 180(2):217-223. PubMed ID: 29230799
[TBL] [Abstract][Full Text] [Related]
33. Serum soluble interleukin-2 receptor level at diagnosis predicts transformation in patients with follicular lymphoma.
Umino K; Fujiwara SI; Ito S; Mashima K; Minakata D; Nakano H; Yamasaki R; Kawasaki Y; Sugimoto M; Ashizawa M; Hatano K; Okazuka K; Sato K; Oh I; Ohmine K; Suzuki T; Muroi K; Kanda Y
Leuk Lymphoma; 2017 Feb; 58(2):316-323. PubMed ID: 27267694
[TBL] [Abstract][Full Text] [Related]
34. Epidemiology of Follicular Lymphoma.
Cerhan JR
Hematol Oncol Clin North Am; 2020 Aug; 34(4):631-646. PubMed ID: 32586570
[TBL] [Abstract][Full Text] [Related]
35. Indolent lymphoma: follicular lymphoma and the microenvironment-insights from gene expression profiling.
Rimsza LM; Jaramillo MC
Hematology Am Soc Hematol Educ Program; 2014 Dec; 2014(1):163-8. PubMed ID: 25696850
[TBL] [Abstract][Full Text] [Related]
36. Unmet needs in the first-line treatment of follicular lymphoma.
Casulo C; Nastoupil L; Fowler NH; Friedberg JW; Flowers CR
Ann Oncol; 2017 Sep; 28(9):2094-2106. PubMed ID: 28430865
[TBL] [Abstract][Full Text] [Related]
37. Follicular lymphoma: is there an optimal way to define risk?
Casulo C
Hematology Am Soc Hematol Educ Program; 2021 Dec; 2021(1):313-319. PubMed ID: 34889370
[TBL] [Abstract][Full Text] [Related]
38. Critical influences on the pathogenesis of follicular lymphoma.
Küppers R; Stevenson FK
Blood; 2018 May; 131(21):2297-2306. PubMed ID: 29666116
[TBL] [Abstract][Full Text] [Related]
39. Novel immunotherapy approaches to follicular lymphoma.
Flowers CR; Leonard JP; Nastoupil LJ
Hematology Am Soc Hematol Educ Program; 2018 Nov; 2018(1):194-199. PubMed ID: 30504310
[TBL] [Abstract][Full Text] [Related]
40. Open questions in watchful waiting for follicular lymphoma.
Sorigue M; Sancho JM; Ribera JM
Br J Haematol; 2017 Nov; 179(4):679-681. PubMed ID: 27390920
[No Abstract] [Full Text] [Related]
[Previous] [Next] [New Search]
